| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $23.81M | $22.81M | $16.15M | $27.99M | $30.55M |
| SG&A | $7.18M | $4.27M | $5.52M | $8.01M | $9.61M |
| Operating Income | -$32.97M | -$28.03M | -$22.87M | -$38.89M | -$43.15M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $5.00K | $42.00K | $69.00K | $129.00K | – |
| Net Income | -$34.17M | -$29.02M | -$23.86M | -$39.56M | -$42.60M |
| EPS (basic) | 2.0900 | 4.9100 | 16.9900 | 2.0400 | 2.2800 |
| EPS (diluted) | 2.0900 | 4.9100 | 16.9300 | 2.0400 | 2.2800 |
| Shares (diluted) | $16.35M | $5.91M | $1.42M | $19.43M | $18.72M |